These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 22405919

  • 1. Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists.
    Yoo E, Hayat F, Rhim H, Park Choo HY.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2707-12. PubMed ID: 22405919
    [Abstract] [Full Text] [Related]

  • 2. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P, Subra G, Verdie P, Gabzdyl E, Bojarski AJ, Duszyńska B, Martinez J, Pawłowski M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4827-31. PubMed ID: 19560916
    [Abstract] [Full Text] [Related]

  • 3. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.
    López-Rodríguez ML, Porras E, Morcillo MJ, Benhamú B, Soto LJ, Lavandera JL, Ramos JA, Olivella M, Campillo M, Pardo L.
    J Med Chem; 2003 Dec 18; 46(26):5638-50. PubMed ID: 14667218
    [Abstract] [Full Text] [Related]

  • 4. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
    Zajdel P, Kurczab R, Grychowska K, Satała G, Pawłowski M, Bojarski AJ.
    Eur J Med Chem; 2012 Oct 18; 56():348-60. PubMed ID: 22926225
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists.
    Nirogi RV, Daulatabad AV, Parandhama G, Mohammad S, Sastri KR, Shinde AK, Dubey PK.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4440-3. PubMed ID: 20594839
    [Abstract] [Full Text] [Related]

  • 6. Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands.
    Szalata C, Szymoniak J, Fabis F, Butt-Gueulle S, Rault S, Bertus P, Gérard S, Sapi J.
    ChemMedChem; 2013 Jan 01; 8(1):70-3. PubMed ID: 23129513
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.
    Yoo E, Yoon J, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY.
    Bioorg Med Chem; 2010 Feb 15; 18(4):1665-75. PubMed ID: 20096593
    [Abstract] [Full Text] [Related]

  • 8. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV, Deshpande AD, Kambhampati R, Badange RK, Kota L, Daulatabad AV, Shinde AK, Ahmad I, Kandikere V, Jayarajan P, Dubey PK.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):346-9. PubMed ID: 21134749
    [Abstract] [Full Text] [Related]

  • 9. N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT₆ receptor antagonists.
    Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK.
    Bioorg Med Chem Lett; 2012 Nov 15; 22(22):6980-5. PubMed ID: 23036955
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S.
    J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651
    [Abstract] [Full Text] [Related]

  • 11. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
    van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG.
    J Med Chem; 2011 Oct 27; 54(20):7030-54. PubMed ID: 21866910
    [Abstract] [Full Text] [Related]

  • 12. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
    Elokdah H, Li D, McFarlane G, Bernotas RC, Robichaud AJ, Magolda RL, Zhang GM, Smith D, Schechter LE.
    Bioorg Med Chem; 2007 Sep 15; 15(18):6208-26. PubMed ID: 17624788
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.
    Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM.
    J Med Chem; 2011 Dec 08; 54(23):8161-73. PubMed ID: 22029285
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.
    Moritomo A, Yamada H, Watanabe T, Itahana H, Akuzawa S, Okada M, Ohta M.
    Bioorg Med Chem; 2013 Dec 15; 21(24):7841-52. PubMed ID: 24189186
    [Abstract] [Full Text] [Related]

  • 15. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I, Alonso-Cires L, López-Tudanca PL, Mosquera R, Labeaga L, Innerárity A, Orjales A.
    J Med Chem; 1999 Jul 29; 42(15):2870-80. PubMed ID: 10425096
    [Abstract] [Full Text] [Related]

  • 16. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I.
    Eur J Med Chem; 2011 Apr 29; 46(4):1189-97. PubMed ID: 21333408
    [Abstract] [Full Text] [Related]

  • 17. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, Zhang G, Zhou P, Schechter LE.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):379-83. PubMed ID: 15603958
    [Abstract] [Full Text] [Related]

  • 18. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands.
    Chłoń-Rzepa G, Zmudzki P, Zajdel P, Bojarski AJ, Duszyńska B, Nikiforuk A, Tatarczyńska E, Pawłowski M.
    Bioorg Med Chem; 2007 Aug 01; 15(15):5239-50. PubMed ID: 17517514
    [Abstract] [Full Text] [Related]

  • 19. Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
    Canale V, Kurczab R, Partyka A, Satała G, Lenda T, Jastrzębska-Więsek M, Wesołowska A, Bojarski AJ, Zajdel P.
    Eur J Med Chem; 2016 Jan 27; 108():334-346. PubMed ID: 26698537
    [Abstract] [Full Text] [Related]

  • 20. Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M, Marcinkowska M, Bucki A, Pawłowski M, Mitka K, Jaśkowska J, Kowalski P, Kazek G, Siwek A, Wasik A, Wesołowska A, Mierzejewski P, Bienkowski P.
    J Med Chem; 2014 Jun 12; 57(11):4543-57. PubMed ID: 24805037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.